| Date | Form | Description | Docs | XBRL | Pages |
| 05/10/13 | 8-K | Current report filing |
|
5 | |
| 05/03/13 | CT ORDER | Confidential treatment order |
|
1 | |
| 05/02/13 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act |
|
6 | |
| 04/24/13 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
|
200 |
| 04/04/13 | 8-K | Current report filing |
|
5 | |
| 03/28/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/28/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/28/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/25/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 03/20/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...